Form SCHEDULE 13G 20/20 Biolabs, Inc. Filed by: Full Succeed International Ltd
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
20/20 Biolabs, Inc. (Name of Issuer) |
Common Stock, par value $0.01 (Title of Class of Securities) |
90138K101 (CUSIP Number) |
02/19/2026 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
| Rule 13d-1(b) |
| Rule 13d-1(c) |
| Rule 13d-1(d) |
SCHEDULE 13G
|
| CUSIP No. | 90138K101 |
| 1 | Names of Reporting Persons
Full Succeed International Limited | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
VIRGIN ISLANDS, BRITISH
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
651,465.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
6.3 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person: The response to Row 11 above is based on 10,347,232 shares of common stock of the Issuer outstanding as of February 19, 2026.
SCHEDULE 13G
|
| CUSIP No. | 90138K101 |
| 1 | Names of Reporting Persons
Nengyuan Pan | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
CHINA
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
651,465.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
6.3 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: The number of shares stated above represents shares of common stock held by Full Succeed International Limited. The response to Row 11 above is based on 10,347,232 shares of common stock of the Issuer outstanding as of February 19, 2026.
SCHEDULE 13G
|
| CUSIP No. | 90138K101 |
| 1 | Names of Reporting Persons
Wei Lu | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
CHINA
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
651,465.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
6.3 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: The number of shares stated above represents shares of common stock held by Full Succeed International Limited. The response to Row 11 above is based on 10,347,232 shares of common stock of the Issuer outstanding as of February 19, 2026.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
20/20 Biolabs, Inc. | |
| (b) | Address of issuer's principal executive offices:
15810 Gaither Road, Suite 235, Gaithersburg, MD 20877 | |
| Item 2. | ||
| (a) | Name of person filing:
This statement is being jointly filed by Full Succeed International Limited ("Full Succeed"), Nengyuan Pan, an individual, and Wei Lu, an individual (each, a "Reporting Person"). | |
| (b) | Address or principal business office or, if none, residence:
The principal business address of each Reporting Person is 23F, 1333 Lujiazui Ring Road, Pudong New Area, Shanghai, People's Republic of China | |
| (c) | Citizenship:
Full Succeed was organized in the British Virgin Islands. Nengyuan Pan and Wei Lu are citizens of the People's Republic of China. | |
| (d) | Title of class of securities:
Common Stock, par value $0.01 | |
| (e) | CUSIP No.:
90138K101 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). | |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
Full Succeed is the record holder of 651,465 shares of common stock of the Issuer. Nengyuan Pan and Wei Lu are the Directors of Full Succeed and share voting and dispositive power over the shares held by it. Each of Nengyuan Pan and Wei Lu disclaims beneficial ownership of such shares except to the extent of his or her pecuniary interest, if any, in such shares. | |
| (b) | Percent of class:
See Row 11 of the cover page for each Reporting Person. %
| |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
See Rows 5-8 of the cover page for each Reporting Person | ||
| (ii) Shared power to vote or to direct the vote:
See Rows 5-8 of the cover page for each Reporting Person | ||
| (iii) Sole power to dispose or to direct the disposition of:
See Rows 5-8 of the cover page for each Reporting Person | ||
| (iv) Shared power to dispose or to direct the disposition of:
See Rows 5-8 of the cover page for each Reporting Person | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
Exhibit Information
|
Exhibit 1 - Joint Filing Agreement |
ATTACHMENTS / EXHIBITS